Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemotherapy-Induced Hearing Loss and Health Inequality

NCT07553481 is registered in ClinicalTrials.gov with Lancaster University as lead sponsor.

NCT NCT07553481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07553481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemotherapy-Induced Hearing Loss and Health Inequality
Lead sponsor
Lancaster University
Phase
Observational
Overall status
Recruiting
Start date
May 2, 2026
Completion date
September 1, 2028
Enrollment
172 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chemo brain, chemotherapy, hearing